![Richard Lesniewski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Lesniewski
Founder at Madison Vaccines, Inc.
Richard Lesniewski active positions
Companies | Position | Start | End |
---|---|---|---|
Madison Vaccines, Inc.
![]() Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Madison Vaccines, Inc. develops vaccines for patients with prostate cancer. It is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines. The firm develops immunological therapies in patients with minimal residual disease, and for whom the mechanism of action of vaccines is ideally suited. The company was founded by Richard R. Lesniewski and Douglas G. McNeel in 2012 and is headquartered in Madison, WI. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
Founder | 2011-12-31 | - | |
President | 2011-12-31 | - | |
DNASTAR, Inc.
![]() DNASTAR, Inc. Packaged SoftwareTechnology Services DNASTAR, Inc. is a bioinformatics software company that has been innovating since 1984. The private company is based in Madison, WI. The company's flagship product, Lasergene, provides a comprehensive software solution for life science researchers. | Director/Board Member | - | - |
Scarab Genomics LLC
![]() Scarab Genomics LLC BiotechnologyHealth Technology Scarab Genomics LLC specializes in providing the most robust bacterial fermentation host for general/routine recombinant protein expression and nucleic acid production. The private company is based in Madison, WI and was founded by Trevor M. Twose. The company's Clean Genome® technology reduces the mutation rate to almost zero, even under the most stressful conditions. Scarab Genomics offers Clean Genome® LowMut T7, which provides a T7 promoter in the genome for clients wishing to use this expression option rather than the recommended synthetic T5 promoter in the pSX2 vector. Scarab Genomics also offers an insertion sequence (IS) detection kit that tests for the presence of all known E. coli IS elements in any DNA sample of interest. | Director/Board Member | - | - |
Career history of Richard Lesniewski
Former positions of Richard Lesniewski
Companies | Position | Start | End |
---|---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | 2008-12-31 | 2008-12-31 |
GSK PLC | Corporate Officer/Principal | - | - |
Statistics
International
United States | 5 |
United Kingdom | 2 |
Operational
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 5 |
Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
GSK PLC | Health Technology |
Private companies | 3 |
---|---|
Madison Vaccines, Inc.
![]() Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Madison Vaccines, Inc. develops vaccines for patients with prostate cancer. It is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines. The firm develops immunological therapies in patients with minimal residual disease, and for whom the mechanism of action of vaccines is ideally suited. The company was founded by Richard R. Lesniewski and Douglas G. McNeel in 2012 and is headquartered in Madison, WI. | Health Technology |
DNASTAR, Inc.
![]() DNASTAR, Inc. Packaged SoftwareTechnology Services DNASTAR, Inc. is a bioinformatics software company that has been innovating since 1984. The private company is based in Madison, WI. The company's flagship product, Lasergene, provides a comprehensive software solution for life science researchers. | Technology Services |
Scarab Genomics LLC
![]() Scarab Genomics LLC BiotechnologyHealth Technology Scarab Genomics LLC specializes in providing the most robust bacterial fermentation host for general/routine recombinant protein expression and nucleic acid production. The private company is based in Madison, WI and was founded by Trevor M. Twose. The company's Clean Genome® technology reduces the mutation rate to almost zero, even under the most stressful conditions. Scarab Genomics offers Clean Genome® LowMut T7, which provides a T7 promoter in the genome for clients wishing to use this expression option rather than the recommended synthetic T5 promoter in the pSX2 vector. Scarab Genomics also offers an insertion sequence (IS) detection kit that tests for the presence of all known E. coli IS elements in any DNA sample of interest. | Health Technology |
- Stock Market
- Insiders
- Richard Lesniewski
- Experience